Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsBronzwaer, Maxime E S
Depla, Annekatrien C T M
van Lelyveld, Niels
Spanier, Marcel B W
Oosterhout, Yvonne H
van Leerdam, Monique E
Spaander, Manon C W
van Haastert, M
Keller, J J
Koch, A D
Koornstra, J J
van Kouwen, M C A
Mundt, M W
de Ridder, R J
van der Sluys-Veer, A
van Wieren, M
MetadataShow full item record
TitleQuality assurance of colonoscopy within the Dutch national colorectal cancer screening program.
Published inGastrointest Endoscop 2019; 89(1):1-13
PubliekssamenvattingColorectal cancer (CRC) screening is capable of reducing CRC-related morbidity and mortality. Colonoscopy is the reference standard to detect CRC, also providing the opportunity to detect and resect its precursor lesions; colorectal polyps. Therefore, colonoscopy is either used as a primary screening tool or as a subsequent procedure after a positive triage test in screening programs based on non-invasive stool testing or sigmoidoscopy. However, in both settings, colonoscopy is not fully protective for the occurrence of post-colonoscopy CRCs (PCCRCs). Because the majority of PCCRCs are the result of colonoscopy-related factors, a high-quality procedure is of paramount importance to assure optimal effectiveness of CRC screening programs. For this reason, at the start of the Dutch fecal immunochemical test (FIT)-based screening program, quality criteria for endoscopists performing colonoscopies in FIT-positive screenees, as well as for endoscopy centers, were defined. In conjunction, an accreditation and auditing system was designed and implemented. In this report we describe the quality assurance process for endoscopists participating in the Dutch national CRC Screening Program, including a detailed description of the evidence-based quality criteria. We believe that our experience might serve as an example for colonoscopy quality assurance programs in other CRC screening programs.
- Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
- Authors: Medical Advisory Secretariat.
- Issue date: 2009
- Initial results of the National Colorectal Cancer Screening Program in Lithuania.
- Authors: Poskus T, Strupas K, Mikalauskas S, Bitinaitė D, Kavaliauskas A, Samalavicius NE, Saladzinskas Z
- Issue date: 2015 Mar
- Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
- Authors: Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, Fasoli R, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex D, Hassan C, Zappa M, Equipe Working Group.
- Issue date: 2015 Sep
- Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
- Authors: van der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E
- Issue date: 2017 Aug
- Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
- Authors: Toes-Zoutendijk E, van Leerdam ME, Dekker E, van Hees F, Penning C, Nagtegaal I, van der Meulen MP, van Vuuren AJ, Kuipers EJ, Bonfrer JMG, Biermann K, Thomeer MGJ, van Veldhuizen H, Kroep S, van Ballegooijen M, Meijer GA, de Koning HJ, Spaander MCW, Lansdorp-Vogelaar I, Dutch National Colorectal Cancer Screening Working Group.
- Issue date: 2017 Mar